Free Trial

BioLife Solutions (BLFS) Short Interest Ratio & Short Volume

$21.00
+0.17 (+0.82%)
(As of 06/21/2024 ET)

BioLife Solutions Short Interest Data

Current Short Interest
4,020,000 shares
Previous Short Interest
4,020,000 shares
Change Vs. Previous Month
No Change
Dollar Volume Sold Short
$86.35 million
Short Interest Ratio
10.4 Days to Cover
Last Record Date
May 31, 2024
Outstanding Shares
46,070,000 shares
Percentage of Shares Shorted
8.73%
Today's Trading Volume
656,531 shares
Average Trading Volume
254,217 shares
Today's Volume Vs. Average
258%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling BioLife Solutions ?

Sign up to receive the latest short interest report for BioLife Solutions and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

BLFS Short Interest Over Time

BLFS Days to Cover Over Time

BLFS Percentage of Float Shorted Over Time

BioLife Solutions Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
5/31/20244,020,000 shares $86.35 million No ChangeN/A10.4 $21.48
5/15/20244,020,000 shares $92.42 million +12.9%N/A9.5 $22.99
4/30/20243,560,000 shares $62.44 million +14.8%N/A9.1 $17.54
4/15/20243,100,000 shares $48.61 million -3.1%N/A8.2 $15.68
3/31/20243,200,000 shares $59.36 million +5.6%N/A7.8 $18.55
3/15/20243,030,000 shares $52.48 million -7.6%N/A7.5 $17.32
2/29/20243,280,000 shares $55.43 million -7.6%N/A7.7 $16.90
2/15/20243,550,000 shares $64.57 million -1.9%N/A7.9 $18.19
1/31/20243,620,000 shares $61.54 million -10.6%N/A7.2 $17.00
1/15/20244,050,000 shares $70.39 million +1.0%N/A7.1 $17.38
12/31/20234,010,000 shares $65.16 million -5.4%N/A7.3 $16.25
12/15/20234,240,000 shares $63.39 million +4.4%N/A7.9 $14.95
11/30/20234,060,000 shares $50.22 million -1.9%N/A7.5 $12.37
11/15/20234,140,000 shares $51.09 million +4.6%N/A7.9 $12.34
10/31/20233,960,000 shares $40.00 million -6.2%N/A7.3 $10.10
10/15/20234,220,000 shares $50.85 million +15.9%N/A8.3 $12.05
9/30/20233,640,000 shares $50.27 million +11.0%N/A7.9 $13.81
9/15/20233,280,000 shares $42.44 million +3.5%N/A7.2 $12.94
8/31/20233,170,000 shares $41.88 million +5.3%N/A7.4 $13.21
8/15/20233,010,000 shares $36.93 million -9.6%N/A7.8 $12.27
7/31/20233,330,000 shares $66.20 million +7.8%N/A9.3 $19.88
7/15/20233,090,000 shares $60.63 million +2.0%N/A9.8 $19.62
6/30/20233,030,000 shares $66.96 million +13.1%N/A9.9 $22.10
6/15/20232,680,000 shares $61.16 million +1.1%N/A8.8 $22.82
5/31/20232,650,000 shares $61.88 million +5.6%N/A8.5 $23.35
5/15/20232,510,000 shares $48.84 million +3.7%6.3%8.2 $19.46
4/30/20232,420,000 shares $42.50 million +2.5%6.1%8.8 $17.56
4/15/20232,360,000 shares $46.94 million +10.8%5.9%8 $19.89
3/31/20232,130,000 shares $46.33 million +0.5%5.3%6.6 $21.75
3/15/20232,120,000 shares $45.54 million +10.4%5.4%6.7 $21.48
2/28/20231,920,000 shares $44.66 million +3.2%4.9%6.1 $23.26
2/15/20231,860,000 shares $44.01 million -7.5%4.7%5.8 $23.66
1/31/20232,010,000 shares $47.11 million -13.7%5.1%5.3 $23.44
1/15/20232,330,000 shares $54.85 million -5.7%5.9%6.1 $23.54
12/30/20222,470,000 shares $44.95 million -2.4%6.2%6.6 $18.20
12/15/20222,530,000 shares $47.49 million -17.9%6.4%6.7 $18.77
11/30/20223,080,000 shares $65.20 million +1.7%7.8%8.3 $21.17
11/15/20223,030,000 shares $74.54 million +16.1%7.7%8.5 $24.60
10/31/20222,610,000 shares $61.39 million +1.6%6.6%7.8 $23.52
10/15/20222,570,000 shares $52.15 million +4.5%6.5%8.2 $20.29
Exposed: 3 CENT Crypto to Explode June 24th? (Ad)

Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 different coins that have returned over 100%... Today, he is now making the biggest crypto call of his ENTIRE career…

Click For My #1 FREE Crypto for 2024
9/30/20222,460,000 shares $55.97 million +2.1%6.3%7.5 $22.75
9/15/20222,410,000 shares $62.52 million +2.1%6.1%6.4 $25.94
8/31/20222,360,000 shares $55.72 million -2.9%6.0%6.2 $23.61
8/15/20222,430,000 shares $63.20 million -3.6%6.2%5.8 $26.01
7/31/20222,520,000 shares $48.56 million +12.0%6.4%5.5 $19.27
7/15/20222,250,000 shares $35.80 million +0.9%5.8%4.6 $15.91
6/30/20222,230,000 shares $30.80 million +43.9%5.7%4.5 $13.81
6/15/20221,550,000 shares $21.86 million +3.3%12.0%3.2 $14.10
5/31/20221,500,000 shares $20.58 million +4.9%3.8%3.3 $13.72
5/15/20221,430,000 shares $17.76 million +13.5%3.7%3.2 $12.42
4/30/20221,260,000 shares $15.96 million +18.9%3.2%3.2 $12.67
4/15/20221,060,000 shares $17.96 million +1.9%2.7%2.7 $16.94
3/31/20221,040,000 shares $23.64 million -27.3%2.7%2.8 $22.73
3/15/20221,430,000 shares $30.53 million -22.7%3.7%3.7 $21.35
2/28/20221,850,000 shares $43.48 million -7.5%4.8%4.4 $23.50
2/15/20222,000,000 shares $53.58 million +7.0%5.2%4.7 $26.79
1/31/20221,870,000 shares $55.80 million +13.3%4.8%4.2 $29.84
1/15/20221,650,000 shares $50.89 million -9.8%4.3%3.7 $30.84
12/31/20211,830,000 shares $68.20 million +8.9%4.7%4.3 $37.27
12/15/20211,680,000 shares $58.38 million +0.6%4.3%4.1 $34.75
11/30/20211,670,000 shares $63.73 million +42.7%4.3%4.8 $38.16
11/15/20211,170,000 shares $57.61 million -18.8%3.0%2.2 $49.24
10/29/20211,440,000 shares $76.54 million -8.9%3.8%2.9 $53.15
10/15/20211,580,000 shares $64.67 million -4.8%4.3%3.6 $40.93
9/30/20211,660,000 shares $70.25 million -20.2%4.5%3.8 $42.32
9/15/20212,080,000 shares $99.96 million -16.8%5.6%4.6 $48.06
8/31/20212,500,000 shares $145.90 million +93.8%6.9%5.6 $58.36
8/13/20211,290,000 shares $58.46 million -0.8%3.6%5.3 $45.32
7/30/20211,300,000 shares $60.97 million -9.7%3.6%5.2 $46.90
7/15/20211,440,000 shares $62.71 million +1.4%4.0%5.2 $43.55
6/30/20211,420,000 shares $63.20 million +30.3%3.9%5.1 $44.51
6/15/20211,090,000 shares $43.16 million +35.8%3.0%3.8 $39.60
5/28/2021802,800 shares $26.74 million -0.4%2.3%2.7 $33.31
5/14/2021806,000 shares $23.80 million +20.8%2.3%2.7 $29.53
4/30/2021667,300 shares $23.08 million -7.6%2.3%2.2 $34.59
4/15/2021722,200 shares $24.26 million -27.5%2.5%2.4 $33.59
3/31/2021995,600 shares $35.80 million +28.7%3.4%3.2 $35.96
3/15/2021773,700 shares $29.38 million +20.9%2.7%2.5 $37.97
2/26/2021640,000 shares $24.95 million +10.2%2.2%2.1 $38.99
2/12/2021580,800 shares $24.16 million -5.0%2.0%1.9 $41.59
1/29/2021611,400 shares $23.42 million -12.8%2.1%1.9 $38.31
1/15/2021701,400 shares $29.41 million No Change2.5%2.1 $41.93
1/31/20201,610,000 shares $22.20 million -0.6%10.6%10.7 $13.79
1/15/20201,610,000 shares $25.52 million -0.6%10.6%10.7 $15.85
12/31/20191,620,000 shares $26.16 million -5.8%10.7%11.2 $16.15

BLFS Short Interest - Frequently Asked Questions

What is BioLife Solutions' current short interest?

Short interest is the volume of BioLife Solutions shares that have been sold short but have not yet been closed out or covered. As of May 31st, investors have sold 4,020,000 shares of BLFS short. Learn More on BioLife Solutions' current short interest.

What is a good short interest ratio for BioLife Solutions?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BLFS shares currently have a short interest ratio of 10.0. Learn More on BioLife Solutions's short interest ratio.

Which institutional investors are shorting BioLife Solutions?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of BioLife Solutions: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

How does BioLife Solutions' short interest compare to its competitors?

Here is how the short interest of companies compare to BioLife Solutions: LivaNova PLC (4.82%), CONMED Co. (12.56%), InMode Ltd. (8.32%), Soleno Therapeutics, Inc. (16.04%), AxoGen, Inc. (4.05%), Zynex, Inc. (33.16%), Semler Scientific, Inc. (8.70%), Edap Tms S.A. (0.27%), Outset Medical, Inc. (16.84%), FONAR Co. (0.15%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($4.43 billion), Charter Communications, Inc. ($3.54 billion), Occidental Petroleum Co. ($3.11 billion), Moderna, Inc. ($2.88 billion), General Motors ($2.62 billion), Royal Caribbean Cruises Ltd. ($2.34 billion), Coinbase Global, Inc. ($2.25 billion), Tractor Supply ($2.12 billion), Dell Technologies Inc. ($1.89 billion), and Enphase Energy, Inc. ($1.72 billion). View all of the most shorted stocks.

What does it mean to sell short BioLife Solutions stock?

Short selling BLFS is an investing strategy that aims to generate trading profit from BioLife Solutions as its price is falling. BLFS shares are trading up $0.17 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against BioLife Solutions?

A short squeeze for BioLife Solutions occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of BLFS, which in turn drives the price of the stock up even further.

How often is BioLife Solutions' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BLFS, twice per month. The most recent reporting period available is May, 31 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:BLFS) was last updated on 6/23/2024 by MarketBeat.com Staff

From Our Partners